These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 32434935)
1. Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry. Escudero-Martinez I; Mazya M; Teutsch C; Lesko N; Gdovinova Z; Barbarini L; Fryze W; Karlinski M; Kobayashi A; Krastev G; Paiva Nunes A; Pasztoova K; Peeters A; Sobolewski P; Vilionskis A; Toni D; Ahmed N; BMJ Open; 2020 May; 10(5):e037234. PubMed ID: 32434935 [TBL] [Abstract][Full Text] [Related]
2. Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke - a single centre experience. Włodarczyk E; Sawczyńska K; Wrona P; Słowik A Neurol Neurochir Pol; 2023; 57(6):465-476. PubMed ID: 37955597 [TBL] [Abstract][Full Text] [Related]
3. Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profile. Matos-Ribeiro J; Castro-Chaves P; Oliveira-Ferreira M; Fonseca L; Pintalhao M J Neurol; 2022 Apr; 269(4):2099-2112. PubMed ID: 34499205 [TBL] [Abstract][Full Text] [Related]
4. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Seiffge DJ; Werring DJ; Paciaroni M; Dawson J; Warach S; Milling TJ; Engelter ST; Fischer U; Norrving B Lancet Neurol; 2019 Jan; 18(1):117-126. PubMed ID: 30415934 [TBL] [Abstract][Full Text] [Related]
5. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies. Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967 [TBL] [Abstract][Full Text] [Related]
6. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience. Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757 [TBL] [Abstract][Full Text] [Related]
7. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K; Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system. Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456 [TBL] [Abstract][Full Text] [Related]
9. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M; Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108 [TBL] [Abstract][Full Text] [Related]
10. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study. Zapata-Wainberg G; Masjuan J; Quintas S; Ximénez-Carrillo Á; García Pastor A; Martínez Zabaleta M; Cardona P; Freijo Guerrero MM; Llull L; Benavente Fernández L; Castellanos Rodrigo M; Egido J; Serena J; Vivancos J; Eur J Neurol; 2019 Feb; 26(2):230-237. PubMed ID: 30153363 [TBL] [Abstract][Full Text] [Related]
11. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation. Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181 [TBL] [Abstract][Full Text] [Related]
13. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke. Beharry J; Waters MJ; Drew R; Fink JN; Wilson D; Campbell BCV; Parsons MW; Kleinig TJ; Wu TY Stroke; 2020 May; 51(5):1616-1619. PubMed ID: 32208845 [TBL] [Abstract][Full Text] [Related]
14. Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study. Grosse GM; Weimar C; Kuklik N; Hüsing A; Stang A; Brinkmann M; Eschenfelder CC; Diener HC; Eur Stroke J; 2021 Dec; 6(4):438-444. PubMed ID: 35342819 [TBL] [Abstract][Full Text] [Related]
15. Early Dabigatran Treatment After Transient Ischemic Attack and Minor Ischemic Stroke Does Not Result in Hemorrhagic Transformation. Alrohimi A; Ng K; Dowlatshahi D; Buck B; Stotts G; Thirunavukkarasu S; Shamy M; Kalashyan H; Sivakumar L; Shuaib A; Sharma M; Butcher K Can J Neurol Sci; 2020 Sep; 47(5):604-611. PubMed ID: 32342831 [TBL] [Abstract][Full Text] [Related]
16. Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report. Lin YT; Lai YJ; Lai TH J Emerg Med; 2020 Mar; 58(3):e113-e116. PubMed ID: 31744711 [TBL] [Abstract][Full Text] [Related]
17. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report. Agosti S; Casalino L; Rocci E; Zaccone G; Rota E J Med Case Rep; 2017 Aug; 11(1):224. PubMed ID: 28806993 [TBL] [Abstract][Full Text] [Related]
18. Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation. Giustozzi M; Acciarresi M; Agnelli G; Caso V; Bandini F; Tsivgoulis G; Yaghi S; Furie KL; Tadi P; Becattini C; Zedde M; Abdul-Rahim AH; Lees KR; Alberti A; Venti M; D'Amore C; Giulia Mosconi M; Anna Cimini L; Bovi P; Carletti M; Rigatelli A; Cappellari M; Putaala J; Tomppo L; Tatlisumak T; Marcheselli S; Pezzini A; Poli L; Padovani A; Vannucchi V; Sohn SI; Lorenzini G; Tassi R; Guideri F; Acampa M; Martini G; Ntaios G; Athanasakis G; Makaritsis K; Karagkiozi E; Vadikolias K; Liantinioti C; Theodorou A; Halvatsiotis P; Mumoli N; Galati F; Sacco S; Tiseo C; Corea F; Ageno W; Bellesini M; Silvestrelli G; Ciccone A; Lanari A; Scoditti U; Denti L; Mancuso M; Ferrari E; Ulivi L; Orlandi G; Giannini N; Tassinari T; Luisa De Lodovici M; Rueckert C; Baldi A; Toni D; Letteri F; Giuntini M; Maria Lotti E; Flomin Y; Pieroni A; Kargiotis O; Karapanayiotides T; Monaco S; Maimone Baronello M; Csiba L; Szabó L; Chiti A; Giorli E; Del Sette M; Imberti D; Zabzuni D; Doronin B; Volodina V; Michel P; Vanacker P; Barlinn K; Barlinn J; Deleu D; Gourbali V; Paciaroni M; Masotti L Stroke; 2020 Aug; 51(8):2347-2354. PubMed ID: 32646335 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of early anticoagulation after endovascular treatment in patients with atrial fibrillation. Xu Y; Liu C; Li W; Nie X; Huang S; Li X; Wu Y; Jin WS; Jiang J; Dong J; Yang Y; Sun Z; Han W; Wang Y; Liu L; Zhang M Stroke Vasc Neurol; 2023 Oct; 8(5):405-412. PubMed ID: 36972921 [TBL] [Abstract][Full Text] [Related]
20. Early anticoagulation in patients with stroke and atrial fibrillation is associated with fewer ischaemic lesions at 1 month: the ATTUNE study. Sharobeam A; Lin L; Lam C; Garcia-Esperon C; Gawarikar Y; Patel R; Lee-Archer M; Wong A; Roizman M; Gilligan A; Lee A; Tan KM; Day S; Levi C; Davis SM; Parsons M; Yan B Stroke Vasc Neurol; 2024 Feb; 9(1):30-37. PubMed ID: 37247875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]